Literature DB >> 6591602

The detailed distribution of MHC Class II antigens in normal human organs.

A S Daar, S V Fuggle, J W Fabre, A Ting, P J Morris.   

Abstract

In a previous article we described the detailed tissue distribution of MHC class I antigens. In this study, we have used a monoclonal antibody, NFK1, to study the tissue distribution of MHC class II antigens. This antibody, which detects a monomorphic determinant common to the DR, SB, and DC molecules, was used to stain frozen sections of normal tissues from throughout the human body by a sensitive peroxidase-antiperoxidase immunohistological technique. Although previous studies, both in animal models and in human beings, have shown that class II antigens are expressed on a limited number of nonlymphoid tissues, our study has extended the spectrum of tissues on which this class of antigens is detectable. Epithelial cells in a number of organs were positively stained--these include the tongue, tonsils, epiglottis, trachea, small intestine, urethra, epididymis, and proximal renal tubules. Lymphatics throughout the body appeared to express class II antigens. Capillaries in brain, testis, and placenta appeared not to express class II antigens, but in the rest of the body they showed strong and uniform staining. These and other observations, and their implications, are discussed in relation to previously published studies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6591602     DOI: 10.1097/00007890-198409000-00019

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  93 in total

1.  Luteinization of human granulosa cells in vivo is associated with expression of MHC class II antigens.

Authors:  E L Khoury; L A Marshall
Journal:  Cell Tissue Res       Date:  1990-11       Impact factor: 5.249

2.  The in-vitro inhibition of rat alloantigen presentation by immunotoxins--implications for allografting.

Authors:  K N Wiley; A Clark; M Fox
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

3.  Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease.

Authors:  D C Mabey; R L Bailey; D Dunn; D Jones; J H Williams; H C Whittle; M E Ward
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

4.  The role of interferon gamma in the pathogenesis of Crohn's disease.

Authors:  T Sasaki; N Hiwatashi; H Yamazaki; M Noguchi; T Toyota
Journal:  Gastroenterol Jpn       Date:  1992-02

5.  Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.

Authors:  S L Saidman; R J Duquesnoy; A Zeevi; J J Fung; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

6.  Towards the phenotyping of soft tissue tumours by cell surface molecules.

Authors:  G Mechtersheimer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

7.  Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells.

Authors:  Azizul Haque; Laela M Hajiaghamohseni; Ping Li; Katherine Toomy; Janice S Blum
Journal:  Cell Immunol       Date:  2007-12-11       Impact factor: 4.868

8.  HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.

Authors:  F Esteban; F Ruiz-Cabello; A Concha; M Pérez-Ayala; J A Sánchez-Rozas; F Garrido
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

9.  Increased epithelial expression of HLA-DQ and HLA-DP molecules in salivary glands from patients with Sjögren's syndrome compared with obstructive sialadenitis.

Authors:  P S Thrane; T S Halstensen; H R Haanaes; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

10.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.

Authors:  A J Demetris; R Jaffe; D G Sheahan; J Burnham; J Spero; S Iwatsuki; D H Van Theil; T E Starzl
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.